Role of Ca2+-activated KCa3.1 potassium channel in CAR T cell effector function
The Journal of Immunology · 15.04.2026 · 215 (4)
DOI: 10.1093/jimmun/vkag078 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 07.05.2026. Verfasst von Vivien Jusztus und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary. Hauptthemen laut MEDLINE: Intermediate-Conductance Calcium-Activated Potassium Channels, T-Lymphocytes, Receptors, Chimeric Antigen, Calcium. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research, Development and Innovation Office, University of Debrecen Program for Scientific Publication, University of Debrecen Scientific Research Bridging Fund.
Abstract (Originalsprache)
Genetically modified chimeric antigen receptor (CAR) T cells eliminate tumors by recognizing specific antigens on the cell surface. T cell ion channels (e.g. Kv1.3, KCa3.1) influence activation, proliferation, and effector functions such as target cell killing, through the regulation of Ca2+ signaling. We showed that CAR-expressing cells (Jurkat) specifically eliminate tumor cells (Raji B cells) in monolayer culture and inhibition of KCa3.1 by TRAM34 increased the tumor cell–killing ability of KCa3.1+ Jurkat CARs. Blockage of KCa3.1 facilitated the migration of KCa3.1+ Jurkat CARs (mean speed, displacement and distance). The application of TRAM34 lowered the baseline Ca2+ level in mCherry-KCa3.1+ Jurkat CARs. Finally, TRAM34 significantly reduced the time needed to eliminate tumor cells. We concluded that expression and modification of KCa3.1 ion channels shifts the intracellular Ca2+ concentration into the range where cytotoxicity dominates. Hence, modification of KCa3.1 channels could contribute to a more effective anticancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
- Division of Dental Biochemistry, Department of Basic Medical Sciences, Faculty of Dentistry, University of Debrecen, Debrecen, Hungary.
ORCID-Profile: Vivien Jusztus
Förderung
- National Research, Development and Innovation Office
- University of Debrecen Program for Scientific Publication
- University of Debrecen Scientific Research Bridging Fund
- EKÖP-25-4 University Research Scholarship Program of the Ministry for Culture and Innovation
- the National Research, Development and Innovation Fund
Zitieren
APA
Jusztus, V., Hajdu, M., Horváth, P., Panyi, G., & Hajdu, P. (2026). Role of Ca2+-activated KCa3.1 potassium channel in CAR T cell effector function. The Journal of Immunology, 215(4). https://doi.org/10.1093/jimmun/vkag078
Vancouver
Jusztus V, Hajdu M, Horváth P, Panyi G, Hajdu P. Role of Ca2+-activated KCa3.1 potassium channel in CAR T cell effector function. The Journal of Immunology. 2026;215(4). doi:10.1093/jimmun/vkag078
BibTeX
@article{Jusztus2026,
author = {Jusztus, Vivien and Hajdu, Márton and Horváth, Péter and Panyi, György and Hajdu, Péter},
title = {Role of Ca2+-activated KCa3.1 potassium channel in CAR T cell effector function},
journal = {The Journal of Immunology},
year = {2026},
volume = {215},
number = {4},
doi = {10.1093/jimmun/vkag078}
}
EUVIMED